The WIPO Treaty: A Guide to Mandatory Disclosure of Origin for Genetic Resources and Traditional Knowledge in Patent Applications

For decades, the global patent system operated with a glaring blind spot. Researchers could travel to biodiversity hotspots, study how indigenous communities used local plants for healing, isolate the active compounds, and patent the resulting drugs—often without ever acknowledging or compensating the communities that guided them.[1][3]

This practice, widely criticized as "biopiracy," has fueled a long-standing tension between intellectual property law and indigenous rights. Pharmaceutical, agricultural, and biotechnology companies relied heavily on the natural world, yet the legal frameworks governing their discoveries rarely required them to disclose where their foundational materials came from.[3]

That paradigm is now fundamentally shifting. Following more than two decades of negotiations, the World Intellectual Property Organization (WIPO) adopted a landmark international agreement: the Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (GRATK).[2]

The treaty establishes a mandatory disclosure requirement for patent applicants worldwide. If an invention is based on genetic resources or traditional knowledge, the applicant must explicitly name the country of origin or the indigenous community that provided the source material.

While the treaty was formally adopted in May 2024, its operational impact is coming into focus as member states move through the ratification process. The agreement enters into force three months after 15 nations formally ratify it, setting a new global baseline for transparency in the life sciences.

To understand the mechanism, it is essential to define what triggers the disclosure. The treaty relies on a specific "based on" test. According to the U.S. Patent and Trademark Office, the requirement is activated only if the genetic resource or traditional knowledge was "necessary for the claimed invention" and the invention "depends on the specific properties" of that resource.[2]

This two-pronged test is designed to strike a balance. It ensures that direct derivations from indigenous knowledge are credited, while preventing the disclosure requirement from becoming an administrative burden for inventions that only tangentially involve biological materials, such as standard laboratory reagents.[3]

If an applicant knows the origin of the genetic resource or the community that provided the traditional knowledge, they must state it in their patent filing. If the specific community is unknown, they must disclose the broader source. If even the source is genuinely unknown, the applicant must submit a formal declaration affirming that lack of knowledge.[2]

Crucially, the WIPO treaty focuses on transparency rather than direct financial redistribution. It does not explicitly mandate benefit-sharing or royalties within the patent system itself. Instead, by forcing disclosure, it creates a public record that indigenous communities and national governments can use to enforce separate access and benefit-sharing agreements, such as those established under the Nagoya Protocol.[1]

The enforcement mechanisms reflect a compromise between developing nations, which pushed for strict penalties, and industrialized nations, which sought to protect the legal certainty of patents. If an applicant fails to disclose the required information, patent offices must provide an opportunity to rectify the omission.[1]

However, if an applicant demonstrates fraudulent intent—deliberately hiding the origin of a genetic resource to bypass benefit-sharing obligations—nations are permitted to impose post-grant sanctions. Even in cases of fraud, the treaty stipulates that a patent should not be revoked or invalidated solely based on the failure to disclose, preserving the stability of the intellectual property system.[1]

The treaty also includes a strict non-retroactivity clause. The new disclosure obligations will only apply to patent applications filed after the treaty enters into force in a given jurisdiction. Existing patents and pending applications are exempt, ensuring that current pharmaceutical and agricultural portfolios remain legally secure.[2]

To facilitate this new era of transparency, the treaty encourages the creation of specialized information systems. WIPO envisions databases of genetic resources and traditional knowledge, developed in consultation with indigenous peoples, which patent examiners can use to verify claims and assess the novelty of new applications.[3]

These databases address a secondary problem in patent law: the granting of erroneous patents. Because traditional knowledge is often passed down orally rather than published in scientific journals, patent examiners frequently lack the "prior art" needed to reject applications that merely copy existing indigenous practices.[3]

Despite its historic nature, the treaty leaves several complex issues unresolved. One of the most significant debates concerns Digital Sequence Information (DSI). Modern biotechnology often relies on digitized genetic codes rather than physical biological samples. The current treaty text does not explicitly cover DSI, leaving a potential loophole for researchers who access genetic data from online repositories.[3]

The treaty includes an in-built review mechanism to address these evolving technological realities. Four years after the agreement enters into force, member states will convene to evaluate its effectiveness and consider expanding the disclosure requirements to cover derivatives and emerging technologies like DSI.[3]

For the biotechnology and pharmaceutical industries, the treaty signals a permanent shift in compliance protocols. Corporate patent strategies must now integrate origin verification from the earliest stages of research and development, ensuring that access to biological materials is thoroughly documented.[3]

Ultimately, the GRATK Treaty represents a profound doctrinal evolution in international law. It is the first WIPO treaty to specifically include provisions for indigenous peoples, formally recognizing their role as stewards of global biodiversity and integrating their rights into the architecture of the global economy.[1]